Business R&D

Research & Development

We are different in R&D.

Today, we decide to focus on Biosimilars and Generic R&D, beyond regular approach. We are looking for more affordable treatment solutions according the needs of patients and our people. Therefore our R&D is integrated with our clinical expertise in developing products.

Alongside, we are involved in New Biological Products development as well. Innovation, Creativity, thinking and ethics are merged to form our concept in formulation of our products.

This approach enables our team to develop and work on new formulations which are difficult-to-manufacture and difficult-to-formulate and improved innovation.

We are also renowned for qualified, effective and affordable medicines. So when it comes to choosing the best generic, our brands are the products you could trust.

Ethical Issue

Ethical issues are the basic of all activities we do in discovery, development and production of pharmaceutical products. We believe ethics should be applied to every steps in the process of bringing a new product to the market related to:

  • Animal
  • Gene & Stem cells
  • Human

R&D Area

According to our scientific approach and experience and available platforms in different our R&D labs and pilot plants, we are active more in the therapeutic areas such as:

  • Oncology
  • Vaccines & Immunology
  • Hematology
  • Cardiovascular
  • Neuroscience
  • HRT

Development Platforms

Clinical Trials

In clinical studies, human volunteers are involved in tests for new ways to prevent, detect, diagnose or treat diseases. They ensure investigational vaccines, medicines, or new uses for existing medicines are safe and effective. We are highly grateful to patients and healthy volunteers who participate in our clinical trials for testing potential therapies. They made a great decision and they are our partners in research.

  • Current Trials:

Barkat is conducting and sponsoring clinical trials in different areas in collaboration with scientific institute and organization to evaluate the efficacy and safety of innovative therapies.

Pilot plant

Our researchers and expertise are involved in scale-up production, before clinical trials or manufacturing start. This means scaling up production from small batches made in the labs to larger scale quantities. We dedicated a facility in this regard.